Skip to Main Content
SickKids

Angela Punnett

Title:
Staff Physician, Haematology/Oncology
Designations:
MD, FRCPC
Phone:
416-813-5394
U of T Positions:
Professor, Department of Paediatrics

Hospital Positions

Interim Associate Chair (Education), Department of Paediatrics

Research Positions

Project Investigator
Child Health Evaluative Sciences

Biography

Dr. Punnett is a Staff Oncologist within the Leukemia/Lymphoma Program in the Division of Haematology/Oncology and Professor in Paediatrics at the University of Toronto. She is a Clinician Educator and former Director of Undergraduate Medical Education for Paediatrics at the University of Toronto.  Dr. Punnett completed MD at the University of Toronto and Paediatrics Residency at the University of Michigan, Ann Arbor. She returned to the University of Toronto for fellowship training in Paediatric Haematology/Oncology at SickKids. 

Research

Punnett leads and participates in clinical research in childhood Leukemia and Lymphoma and is a member of the COG steering committee for Hodgkin Lymphoma. As a clinician educator, she is involved in education scholarship with collaborators in the Department of Paediatrics and nationally. 

Education and experience

  • 1996–2000: Physician, Paediatrics, University of Michigan, Ann Arbor MI
  • 2000–2003: Physician, Paediatric Hematology/Oncology Fellows, University of Toronto, Toronto, ON

Publications

  1. Castellino SM, Li H, MS, Herrera AF, Leblanc M, Parsons SK,, Unger JM, Punnett A, Hodgson D, Keller F, Drachtman RA, Lamble A, Forlenza CJ, Doan A, Rutherford SC, Evens AM, Little R, Smith MA, Hoppe BS, Song JY, Smith SM, Friedberg JW, Kelly KM. Nivolumab-AVD Is Superior to Brentuximab Vedotin-AVD with 3-Year Follow-Up of S1826 in Adolescent Advanced-Stage Classic Hodgkin Lymphoma. J Clinic Oncol 2026;00:1-6. DOI: 10.1200/JCO-25-00203
  2. Hoppe BS, Mailhot-Vega RB, Renfro LA, Pei Q, Charpentier AM, Parikh RR, Roberts KB, Keller FG, Punnett A, Parsons S, Voss SD, Alzaraki A, McCarten KM, Flampouri S, Kessel S, Cho SY, Kelly KM, Castellino SM, Hodgson D. Comparison of contemporary radiotherapy approaches in combined modality treatment on pediatric high-risk classic Hodgkin lymphoma study: AHOD 1331. Internat J Rad Onc Bio Phys 2025;123(4):972-9. https://doi.org/10.1016/j.ijrobp.2025.06.3876
  3. Dakhallah N, Punnett A, Yan A. Concurrent dermatologic and pulmonary bleomycin toxicity in a patient treated for Hodgkin lymphoma. Pediatr Blood Cancer 2025;72(10):e31907. doi: 10.1002/pbc.31907
  4. Williams AM, Rodday AM, Renfro LA, Wu Y, Henderson TO, Keller KG, Punnett A, Hodgson D, Kelly KM, Castellino SM, Parsons SK. Group-based trajectories of health-related quality of life (HRQoL) among patients with high-risk pediatric Hodgkin lymphoma treated on the Children’s Oncology Group (COG) AHOD1331 study. J Natl Cancer Inst 2025;117(10):2112-9. doi: 10.1093/jnci/djaf197
  5. Belsky JA, Renfro LA, Pei Q, Keller FG, Hodgson DC, Punnett A, McCarten K, Cho SY, Wu Y, Kelly KM, Castellino SM, Schwartz CL. Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High-Risk Pediatric Hodgkin Lymphoma Patients Treated on Children’s Oncology Group AHOD1331. Pediatr Blood Cancer 2025 Jun 14:e31856. Doi 10.1002/pbc31856.

View a full list of Angela Punnett's publications

Funding

  • Paediatric Consultants
  • Paediatric Oncology Group of Ontario
  • Physician Services Incorporated
  • Garron Family Cancer Centre
  • Candlelighters
  • C17 Canada
  • University of Toronto Provost’s Instructional Technology Innovation Fund
Back to Top